BioSpace’s layoff tracker reported workforce reductions at major contract research and laboratory services providers including Charles River and Thermo Fisher Scientific alongside site closures. Companies cited operational consolidation and cost management as drivers of the staffing changes. The cuts affect capacity in preclinical and manufacturing services and could ripple through biotech project timelines. Industry watchers say the moves reflect broader pressure on service providers to optimize networks amid shifting demand and rising operating costs.